May 19, 2017 Comments Off on Biotech Slides into Boston’s Fenway Neighborhood Views: 492 Massachusetts, National News, Northeast

Biotech Slides into Boston’s Fenway Neighborhood

Decibel Therapeutics relocated its headquarters and lab space into Samuels & Associates’ Van Ness mixed-use development in Boston’s Fenway neighborhood. The biotech company took 32,000 square feet at 1325 Boylston St., which signals a broader shift in The Fenway’s transformation.

Decibel, which is developing hearing loss treatments, is the first biotech company to move into the area, joining a burgeoning health and technology hub.

Samuels & Associates’ Peter Sougarides says, “Decibel’s headquarters and lab really mark a tipping point for health innovation companies falling in love with The Fenway.”

Van Ness, which opened in summer 2015, consists of a 172-unit residential tower and a 237,000-square-foot office tower atop a 165,000-square-foot retail base.

Decibel Therapeutics’ Steve Holtzman said, “Our new headquarters in The Fenway will enable us to bring our capabilities under one roof, and sustain the cross-disciplinary exchange needed to conduct breakthrough science, while supporting our growth.”

Read more at Business Wire

Connect With Samuels & Associates

Subscribe to Connect Daily National

For comments, questions or concerns, please contact Dennis Kaiser

Tags: ,

Comments are closed.